AC
IRWD icon

AXQ Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

AXQ Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.5K Buy
+12,949
New +$53.1K 0.01% 935
2024
Q4 		– Sell
-14,929
Closed -$61.5K – 535
2024
Q3 		$61.5K Buy
+14,929
New +$80.3K 0.02% 410
2024
Q1 		– Sell
-23,100
Closed -$264K – 761
2023
Q4 		$264K Buy
23,100
+3,100
+16% +$30.7K 0.07% 419
2023
Q3 		$193K Buy
+20,000
New +$196K 0.07% 393

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AXQ Capital's IRWD Position: Q1 2026 in Review

AXQ Capital opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 12,949 shares worth $45.5K. The stake represents 0.01% of the portfolio and ranks #935 among its holdings. This is a return to the name: AXQ Capital previously reported a position in IRWD as recently as Q3 2024.

AXQ Capital first reported a position in IRWD in Q3 2023 and has held it in 4 quarters since. The position peaked at $264K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • AXQ Capital held 12,949 shares of Ironwood Pharmaceuticals worth $45.5K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new AXQ Capital position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.01% of AXQ Capital's portfolio in Q1 2026, its #935 holding.
  • AXQ Capital first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • AXQ Capital's Ironwood Pharmaceuticals position peaked at $264K in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.